A health economic analysis of autologous transfusion

Infusionstherapie und Transfusionsmedizin

Volumn 29, Issue 3, 2002, Pages 175-183

  Sonnenberg, Frank A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Allogeneic transfusion; Autologous transfusion; Cost effectiveness analysis; Cost utility analysis; Decision analysis; Preoperative blood donation

Indexed keywords

AGED; BACTERIAL INFECTION; BLOOD AUTOTRANSFUSION; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ELECTIVE SURGERY; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SIMULATION; TOTAL HIP PROSTHESIS;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036062057     PISSN: 14245485     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064238     Document Type: Conference Paper

References (70)

1. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery
2. The nation's changing blood supply system
3. Safety of the blood supply
4. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States
5. The risk of transfusion-transmitted viral infections
6. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost?
7. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost?
8. Autologous blood donation - Can we bank on it?
9. The ethical workup: Definition and process
10. Autologous-blood transfusion: The reimbursement dilemma
11. Relationship of postoperative septic complications and blood transfusions in patients with Crohn's disease
12. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions
13. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations
14. Association of transfusion with postoperative bacterial infection
15. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery
16. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery
17. Blood transfusions and prognosis in colorectal cancer
18. Postoperative infections following autologous and homologous blood transfusions
19. Blood transfusion and postoperative infection in orthopedic patients
20. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery
21. Immunosuppressive effects of blood transfusion
22. Transfusion-induced immunomodulation and infection
23. Blood transfusion and infection after colorectal cancer surgery
24. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet?
25. Blood transfusion options: Improving outcomes and reducing costs
26. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis
27. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement
28. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting
29. Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures
30. The cost effectiveness of preoperative autologous blood donations
31. The cost-effectiveness of autologous transfusion revisited: Implications of an increased risk of bacterial infection with allogeneic transfusion
32. A clinician's guide to cost-effectiveness analysis
33. The Markov process in medical prognosis
34. Markov models in medical decision making: A practical guide
35. Utility functions for life years and health status
36. A convenient approximation of life expectancy (the 'DEALE'). I. Validation of the method
37. A convenient approximation of life expectancy (the 'DEALE'). II. Use in medical decision-making
38. Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning
39. Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B
40. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
41. The cost effectiveness of combination antiretroviral therapy for HIV disease
42. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip
43. Relationship of hemoglobin level and duration of hospitalization after total hip arthroplasty: Implications for the transfusion target
44. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays
45. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP)
46. Indirect tests for transfusion-transmitted diseases
47. Chronic liver disease after acute non-A, non-B viral hepatitis
48. Natural history and prognostic factors for chronic hepatitis type B
49. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis
50. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population
51. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma
52. Antibody to hepatitis C virus in post-transfusion hepatitis
53. Survival in chronic hepatitis B. An analysis of 379 patients
54. Cancer statistics, 1993
55. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults
56. Postoperative pneumonia in elderly patients: Incidence and mortality in comparison with younger patients
57. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair
58. The Regenstrief Medical Record System: 20 Years of experience in hospitals, clinics, and neighborhood health centers
59. Cost effectiveness of autologous blood donation
60. FDA bans blood donation by people who have lived in UK
61. Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: Systematic review of case-control studies
62. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: A prospective study
63. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients